Tumor neoantigenicity assessment with CSiN score incorporates clonality and immunogenicity to predict immunotherapy outcomes is a research paper published in Science Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 50 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIEHS NIH HHS
Grant: R03 ES026397
Cancer Prevention Research Institute of Texas
Grant: CPRIT RP190208
NCI NIH HHS
Grant: P30 CA142543
Cancer Prevention and Research Institute of Texas
Grant: CPRIT RP180319
American Cancer Society
Grant: RSG-16-004-01-CCE
National Institutes of Health
Grant: SPORE 1P50CA19651601
National Institutes of Health
Grant: CCSG 5P30CA142543
National Institutes of Health
Grant: R03 ES026397-01
National Institutes of Health
Grant: 5R03ES026397-02
Development of integrative models for early liver toxicity assessment
National Institutes of Health
Grant: 3P30CA142543-04S1
Chemistry and Cancer Scientific Program
National Institutes of Health
Grant: 3P30CA142543-12S1
Multidimensional single-cell approach probing HIV-1 integration association with non-AIDS defining cancers (Biospecimens/Biocohort)
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals